Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
Conditions:   Hematopoietic and Lymphoid Cell Neoplasm;   Influenza Interventions:   Drug: Baloxavir Marboxil;   Drug: Oseltamivir Sponsor:   M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2021 Category: Research Source Type: clinical trials

A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A
Condition:   Influenza A Interventions:   Drug: ZSP1273 600 mg;   Drug: Placebo to Oseltamivir;   Drug: Oseltamivir(oral);   Drug: Placebo to ZSP1273 Sponsor:   Guangdong Raynovent Biotech Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 24, 2020 Category: Research Source Type: clinical trials